LONDON (Reuters) - Shire Plc SHP.L has agreed to a U.S. Food and Drug Administration request to study its stimulant Vyvanse in preschool children as concern rises over the diagnosis and treatment of attention deficit hyperactivity disorder, the drugmker ...
from Meta Search Alerts http://ift.tt/TR8JWB
via IFTTT
from Meta Search Alerts http://ift.tt/TR8JWB
via IFTTT
No comments:
Post a Comment